Literature DB >> 21361054

Interdisciplinary consensus document for the treatment of fibromyalgia.

C Alegre de Miquel1, J García Campayo, M Tomás Flórez, J M Gómez Arguelles, E Blanco Tarrio, M Gobbo Montoya, Á Pérez Martin, A Martínez Salio, J Vidal Fuentes, E Altarriba Alberch, A Gómez de la Cámara.   

Abstract

Backgrounds. The elevated prevalence and enormous clinical and social impact of fibromyalgia, together with the complexity of its treatment, require action consensuses that guide health care professionals. Although there are some similar documents in our language, most have been made from the perspective of a single discipline.Objective. To develop a consensus on the treatment of fibromyalgia made by selected representatives and supported by the principal medical associations that intervene in its treatment (rheumatology, neurology, psychiatry,rehabilitation and family medicine) and representatives of the associations of patients. On the other hand, understanding the disease not as a homogenous disorders but also as the sum of different clinical subtypes,having specific symptomatic characteristics and different therapeutic needs is stressed. This approach represented a need perceived by the clinicians and a novelty regarding previous consensuses.Methods. The different clinical classifications proposed in fibromyalgia and the scientific evidence of the treatments used in this disease were reviewed. For the selection of the classification used and performance of the therapeutic recommendations, some of the usual techniques to obtain the consensus (nominal group and brainstorming) were used.Conclusion. The classification of Giesecke of fibromyalgia into 3 subgroups seems to have the greatest scientific evidence and the most useful for the clinician. The guide offers a series of general recommendations for all the patients with fibromyalgia. However, in addition, for each subgroup, there are a series of specific pharmacological and psychological-type recommendations and those of modification of the environment, which will make it possible to have a personalized approach to the patient with fibromyalgia in accordance with their individual clinical characteristics (pain, catastrophizing levels, etc.).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21361054

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  10 in total

1.  [Methodological fundamentals of the development of the guideline].

Authors:  W Häuser; K Bernardy; H Wang; I Kopp
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  [Optimising the use of exercise for the treatment of fibromyalgia].

Authors:  Luis López-Lázaro
Journal:  Aten Primaria       Date:  2012-11       Impact factor: 1.137

Review 3.  Fibromyalgia: Treating Pain in the Juvenile Patient.

Authors:  Sabrina Gmuca; David D Sherry
Journal:  Paediatr Drugs       Date:  2017-08       Impact factor: 3.022

4.  Randomized Controlled Trial of Acupuncture for Women with Fibromyalgia: Group Acupuncture with Traditional Chinese Medicine Diagnosis-Based Point Selection.

Authors:  Scott D Mist; Kim Dupree Jones
Journal:  Pain Med       Date:  2018-09-01       Impact factor: 3.750

5.  Relationship between body mass index, fat mass and lean mass with SF-36 quality of life scores in a group of fibromyalgia patients.

Authors:  Laura Arranz; Miguel Angel Canela; Magda Rafecas
Journal:  Rheumatol Int       Date:  2011-11-18       Impact factor: 2.631

6.  You get used to it, or do you: symptom length predicts less fibromyalgia physical impairment, but only for those with above-average self-efficacy.

Authors:  Charles Van Liew; Gabriel Leon; Mikayla Neese; Terry A Cronan
Journal:  Psychol Health Med       Date:  2018-09-30       Impact factor: 2.423

7.  Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: a randomised controlled trial.

Authors:  Marta Alda; Juan V Luciano; Eva Andrés; Antoni Serrano-Blanco; Baltasar Rodero; Yolanda López del Hoyo; Miquel Roca; Sergio Moreno; Rosa Magallón; Javier García-Campayo
Journal:  Arthritis Res Ther       Date:  2011-10-23       Impact factor: 5.156

Review 8.  Classification and clinical diagnosis of fibromyalgia syndrome: recommendations of recent evidence-based interdisciplinary guidelines.

Authors:  Mary-Ann Fitzcharles; Yoram Shir; Jacob N Ablin; Dan Buskila; Howard Amital; Peter Henningsen; Winfried Häuser
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-26       Impact factor: 2.629

9.  A patient and physician survey of fibromyalgia across Latin America and Europe.

Authors:  Patricia Clark; Eduardo S Paiva; Anna Ginovker; Patricia Arline Salomón
Journal:  BMC Musculoskelet Disord       Date:  2013-06-14       Impact factor: 2.362

10.  Fibromyalgia and Chronic Pain Syndromes: A White Paper Detailing Current Challenges in the Field.

Authors:  Lesley M Arnold; Ernest Choy; Daniel J Clauw; Don L Goldenberg; Richard E Harris; Milton Helfenstein; Troels Staehelin Jensen; Koichi Noguchi; Stuart L Silverman; Takahiro Ushida; Guochun Wang
Journal:  Clin J Pain       Date:  2016-09       Impact factor: 3.442

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.